National Estimates of the Adult Diabetes Care Continuum in India, 2019-2021

Author:

Varghese Jithin Sam12,Anjana Ranjit Mohan3,Geldsetzer Pascal45,Sudharsanan Nikkil67,Manne-Goehler Jennifer8,Thirumurthy Harsha9,Bhattacharyya Soura10,Narayan K. M. Venkat12,Mohan Viswanathan3,Tandon Nikhil11,Ali Mohammed K.1212

Affiliation:

1. Emory Global Diabetes Research Center of Woodruff Health Sciences Center and Emory University, Atlanta, Georgia

2. Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia

3. Madras Diabetes Research Foundation and Dr Mohan’s Diabetes Specialities Centre, Chennai, India

4. Division of Primary Care and Population Health, Department of Medicine, Stanford University, Stanford, California

5. Chan Zuckerberg Biohub−San Francisco, San Francisco, California

6. Professorship of Behavioral Science for Disease Prevention and Health Care, Technical University of Munich, Munich, Germany

7. Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany

8. Division of Infectious Diseases, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts

9. Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia

10. Lattice Innovations, New Delhi, India

11. Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi, India

12. Department of Family and Preventive Medicine, School of Medicine, Emory University, Atlanta, Georgia

Abstract

ImportanceDiabetes is widespread and treatable, but little is known about the diabetes care continuum (diagnosis, treatment, and control) in India and how it varies at the national, state, and district levels.ObjectiveTo estimate the adult population levels of diabetes diagnosis, treatment, and control in India at national, state, and district levels and by sociodemographic characteristics.Design, Setting, and ParticipantsIn this cross-sectional, nationally representative survey study from 2019 to 2021, adults in India from 28 states, 8 union territories, and 707 districts were surveyed for India’s Fifth National Family Health Survey (NFHS-5). The survey team collected data on blood glucose among all adults (18-98 years) who were living in the same household as eligible participants (pregnant or nonpregnant female individuals aged 15-49 years and male individuals aged 15-54 years). The overall sample consisted of 1 895 287 adults. The analytic sample was restricted to those who either self-reported having diabetes or who had a valid measurement of blood glucose.ExposuresThe exposures in this survey study were district and state residence; urban vs rural residence; age (18-39 years, 40-64 years, or ≥65 years); sex; and household wealth quintile.Main Outcomes and MeasuresDiabetes was defined by self-report or high capillary blood glucose (fasting: ≥126 mg/dL [to convert to mmol/L, multiply by 0.0555]; nonfasting: ≥220 mg/dL). Among respondents who had previously been diagnosed with diabetes, the main outcome was the proportion treated based on self-reported medication use and the proportion controlled (fasting: blood glucose <126 mg/dL; nonfasting: ≤180 mg/dL). The findings were benchmarked against the World Health Organization (WHO) Global Diabetes Compact targets (80% diagnosis; 80% control among those diagnosed). The variance in indicators between and within states was partitioned using variance partition coefficients (VPCs).ResultsAmong 1 651 176 adult respondents (mean [SD] age, 41.6 [16.4] years; 867 896 [52.6%] female) with blood glucose measures, the proportion of individuals with diabetes was 6.5% (95% CI, 6.4%-6.6%). Among adults with diabetes, 74.2% (95% CI, 73.3%-75.0%) were diagnosed. Among those diagnosed, 59.4% (95% CI, 58.1%-60.6%) reported taking medication, and 65.5% (95% CI, 64.5%-66.4%) achieved control. Diagnosis and treatment were higher in urban areas, older age groups, and wealthier households. Among those diagnosed in the 707 districts surveyed, 246 (34.8%) districts met the WHO diagnosis target, while 76 (10.7%) districts met the WHO control target. Most of the variability in diabetes diagnosis (VPC, 89.1%), treatment (VPC, 85.9%), and control (VPC, 95.6%) were within states, not between states.Conclusions and RelevanceIn this survey study, the diabetes care continuum in India is represented by considerable district-level variation, age-related disparities, and rural-urban differences. Surveillance at the district level can guide state health administrators to prioritize interventions and monitor achievement of global targets.

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3